MarkDibuonoMD

Psychiatry • Staten Island, NY

Geriatric Psychiatry

Medical Director/ PI , Richmond Behavioral Associates , An Evolution Research Group Portfolio Company

Join to view full profile

Dr. Dibuono is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dibuono's full profile

Already have an account?

Office
260 Christopher Lane
Staten Island, NY 10314
Phone+1 718-317-5522

Fax+1 718-494-5714

Education & Training

Stony Brook Medicine/University HospitalResidency, Psychiatry, 1984 - 1987
Albert Einstein College of Medicine/Montefiore (New Rochelle)Internship, Transitional Year, 1983 - 1984
Universidad Autonoma de GuadalajaraClass of 1981

Certifications & Licensure

NJ State Medical License 1984 - 2025
NY State Medical License 1983 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01
Completed
Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

40 citations
Relapse in delusional depression: A retrospective study of the course of treatment
Thomas A. Aronson, Sashi Shukla, Krishnareddy S. Gujavarty, Anne L. Hoff, Mark DiBuono
Comprehensive Psychiatry. 1988-01-01

Press Mentions

Nws Autism TreatmentDecember 22nd, 2016
Island Doctors Trial New Autism TreatmentDecember 22nd, 2016

Research History

Principal InvestigatorPhase II and III clinical trials assessing safety and efficacy of investigational compounds for treatment of schizophrenia, bipolar disorder, major depressive disorder, autism, neuropathy, and dementia .

Professional Memberships

American Psychiatric Association - APA
Member